While weight loss, improved glycemic control, and reduction in insulin dose may imply an improvement in insulin sensitivity, studies on GLP-1RA treatment using gold-standard methods to assess insulin sensitivity are still needed in different cohorts with T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.